|
Wonderful! and good to hear about those "older" drugs still working really well for lots of people.
I think the reason most docs use the newer drugs as first-line treatment is that they have less on-going side-effects (they still have the start-up ones, but they all mostly go away). If the first-line doesn't work, they have protocols for which to try next. I think it's great that your doc hit on the right one for the second choice. Because the "older" drugs are less specific in their actions, they cause more ongoing side-effects as they act on many brain chemicals (eg amitryptiline can cause anti-cholinergic effects like very dry mouth, weight gain, sluggishness, sleepiness - at least it did for me, without even helping my depression much) and many people do not tolerate it well. That's why it's fallen out of favour as a first-line treatment.
But that's not to say they aren't effective drugs. Congrats...
|